Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.

Publication

Citation
Sutton JM, Clark DE, Dunsdon SJ, Fenton G, Fillmore A, Harris NV, Higgs C, Hurley CA, Krintel SL, MacKenzie RE, Duttaroy A, Gangl E, Maniara W, Sedrani R, Namoto K, Ostermann N, Gerhartz B, Sirockin F, Trappe J, Hassiepen U, Baeschlin DK.: Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes. Bioorg Med Chem Lett, Volume 22 (3), 2012
Authors
Baeschlin DK., Clark DE, Dunsdon SJ, Duttaroy A, Fenton G, Fillmore A, Gangl E, Gerhartz B, Harris NV, Hassiepen U, Higgs C, Hurley CA, Krintel SL, MacKenzie RE, Maniara W, Namoto K, Ostermann N, Sedrani R, Sirockin F, Sutton JM, Trappe J
Journal
Bioorg Med Chem Lett
Year
2012
PubMed
22177783
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc